FIELD: medicine.
SUBSTANCE: invention relates to field of medicine, in particular to medical radiology and can be used in endocrinology and oncology. After introduction of radiopharmpreparation "123I-sodium iodide, isotonic solution", planar scintigraphy of thyroid gland and after that monophoton emission computed tomography are carried out, basing on the results of planar scintigraphy total area of thyroid gland is determined, its value is used to determine individual percent of background cutoff from maximal count on images of sections, whose magnitude in case if total area of thyroid gland is less than 12 cm2, constitutes 60%, more than 12 cm2 and less than 25 cm2, - 55%, more than 25 cm2 and less than 30 cm2 -50%, more than 30 cm2 -44%, then taking into account said parametre using data of monophoton emission computed tomography count of number of volume elements in images of organ sections, which have count value higher than set level, and volume of functioning tissue of thyroid gland is determined in metric units - cm3. Method is highly efficient and self-descriptive. Accurate determination of functioning tissue allows to carry out correction of therapeutic dose of radioactive iodine, which later considerably reduces probability of complications development. Moreover, said information is necessary for selection of treatment tactics and volume of surgery.
EFFECT: method allows to estimate quantitatively with high degree of accuracy ability of thyroid gland parenchyma, namely, calculate volume of functioning tissue using individual value of background cutoff percent.
2 ex
Title | Year | Author | Number |
---|---|---|---|
DIFFERENTIAL DIAGNOSTIC TECHNIQUE FOR THYROPHYMA | 2008 |
|
RU2386398C1 |
METHOD FOR EXAMINING PATIENTS WITH SUSPECTED INFLAMMATION IN THE WALL OF THE ASCENDING AORTA WITH ANEURYSMAL DILATION | 2021 |
|
RU2772636C1 |
USING RADIOPHARMACEUTICAL COMPOSITION USING LABELLED AUTOLOGOUS LEUKOCYTES TO VISUALIZE LOCAL RADIATION LESIONS BY SINGLE-PHOTON EMISSION TOMOGRAPHY | 2018 |
|
RU2708088C2 |
METHOD FOR ASSESSING THE RISK OF RECURRENT DIFFERENTIATED THYROID CANCER AFTER RADIOIODINE THERAPY | 2020 |
|
RU2743275C1 |
METHOD FOR DIAGNOSING INTENSITY AND PREVALENCE OF INFLAMMATORY PROCESS IN CHILDREN SUFFERING TUBERCULOSIS | 2022 |
|
RU2823857C2 |
METHOD FOR TARGETED BRACHYTHERAPY OF PROSTATE CANCER UNDER HYBRID PSMA-RECEPTOR SCINTIGRAPHY NAVIGATION | 2022 |
|
RU2788859C2 |
METHOD FOR RADIONUCLIDE DIAGNOSIS OF PROSTATE CANCER | 2021 |
|
RU2776234C1 |
METHOD OF DIAGNOSING KIDNEY TUMORS | 1994 |
|
RU2085119C1 |
RADIONUCLIDE DIAGNOSTIC TECHNIQUE FOR BREAST CANCER WITH Her2/neu HYPEREXPRESSION | 2019 |
|
RU2720801C1 |
METHOD OF COMBINED RADIONUCLIDE THERAPY OF DIFFERENTIATED THYROID CANCER WITH METASTATIC INVOLVEMENT OF LUNGS AND SKELETON | 2023 |
|
RU2824276C2 |
Authors
Dates
2011-01-10—Published
2009-04-02—Filed